Skip to main content
Back
Watch Compare

Fuse Medical, Inc.

Data quality: 100%
FZMD
OTC Wholesale Trade Durable Goods Wholesale
$0.02
$0.00 (0.00%)
Mkt Cap: 1.48 M
Price
$0.02
Mkt Cap
1.48 M
Day Range
$0.02 — $0.02
52-Week Range
$0.02 — $0.10
Volume
142,040
Open $0.02
50D / 200D Avg
$0.04
46.81% below
50D / 200D Avg
$0.06
67.53% below

Quick Summary

Key Takeaways

Revenue declined -8.28% annually over 5 years
Net margin of 19.72% shows strong profitability
Generating 18,641.0 in free cash flow
P/E of 0.41 — trading at a low valuation

Growth

Revenue Growth (5Y)
-8.28%
Below sector avg (257.90%)
Revenue (1Y)-8.67%
Earnings (1Y)N/A
FCF Growth (3Y)-59.85%

Quality

Return on Equity
N/A
ROIC-3.30%
Net Margin19.72%
Op. Margin-1.30%

Safety

Debt / Equity
N/A
Current Ratio1.06
Interest Coverage-1.13

Valuation

PE (TTM)
0.41
Above sector avg (-27.54)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Wholesale Trade sector median (3 peers)
Metric Stock Sector Median
P/E 0.4 -27.5
P/B — 1.6
ROE % — -2.8
Net Margin % 19.7 -199494.9
Rev Growth 5Y % -8.3 257.9
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -8.67% Revenue Growth (3Y) -6.66%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -8.28% Earnings Growth (5Y) -5.94%
Profitability
Revenue (TTM) 18.40 M Net Income (TTM) 3.63 M
ROE N/A ROA 19.23%
Gross Margin 64.95% Operating Margin -1.30%
Net Margin 19.72% Free Cash Flow (TTM) 18,641.0
ROIC -3.30% FCF Growth (3Y) -59.85%
Safety
Debt / Equity N/A Current Ratio 1.06
Interest Coverage -1.13 Asset Turnover 0.98
Working Capital 754,339 Tangible Book Value -3.33 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 0.41 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.08
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1.26%
Market Cap 1.48 M Enterprise Value 1.22 M
Per Share
EPS (Diluted TTM) 0.04 Revenue / Share 0.25
FCF / Share 0.00 OCF / Share -0.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) -9.64%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 0.51%
SBC-Adj. FCF 1,649 Growth Momentum -0.39

Income Statement

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Revenue 18.64 M 20.41 M 21.40 M 22.90 M 26.34 M
Net Income 3.10 M -1.59 M -1.43 M -3.32 M 3.96 M
EPS (Diluted) 0.04 -0.02 -0.02 -0.05 0.06
Gross Profit 11.54 M 11.94 M 12.70 M 11.14 M 12.99 M
Operating Income -815,072.0 -2.20 M -1.03 M -4.35 M -1.96 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses 6.54 M 7.01 M 6.54 M 8.47 M 8.47 M
D&A 137,403.0 67,638.0 104,143.0 107,073.0 49,685.0
Interest Expense 171,294.0 78,230.0 94,953.0 121,633.0 133,944.0
Income Tax 23,655.0 17,723.0 18,993.0 781,085.0 -386,784.0

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Total Assets 19.76 M 18.30 M 17.42 M 18.38 M 22.17 M
Total Liabilities 20.07 M 21.74 M 19.53 M 19.60 M 20.71 M
Shareholders' Equity -310,854.0 -3.43 M -2.11 M -1.22 M 1.47 M
Total Debt — — — — —
Cash & Equivalents 147,854.0 553,190.0 1.19 M 1.10 M 844,314.0
Current Assets 13.77 M 12.82 M 12.62 M 15.17 M 17.18 M
Current Liabilities 12.39 M 9.94 M 7.25 M 7.96 M 7.12 M